Global Coronary Drug-Eluting Stent Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Coronary Drug-Eluting Stent market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Coronary Drug-Eluting Stent Industry Forecast” looks at past sales and reviews total world Coronary Drug-Eluting Stent sales in 2023, providing a comprehensive analysis by region and market sector of projected Coronary Drug-Eluting Stent sales for 2024 through 2030. With Coronary Drug-Eluting Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coronary Drug-Eluting Stent industry.
This Insight Report provides a comprehensive analysis of the global Coronary Drug-Eluting Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coronary Drug-Eluting Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coronary Drug-Eluting Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coronary Drug-Eluting Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coronary Drug-Eluting Stent.
United States market for Coronary Drug-Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Coronary Drug-Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Coronary Drug-Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Coronary Drug-Eluting Stent players cover Medtronic, Boston Scientific, Abbott, B.Braun and Biosensors International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Coronary Drug-Eluting Stent market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Coronary Drug-Eluting Stent market?
What factors are driving Coronary Drug-Eluting Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coronary Drug-Eluting Stent market opportunities vary by end market size?
How does Coronary Drug-Eluting Stent break out type, application?
The global Coronary Drug-Eluting Stent market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Coronary Drug-Eluting Stent Industry Forecast” looks at past sales and reviews total world Coronary Drug-Eluting Stent sales in 2023, providing a comprehensive analysis by region and market sector of projected Coronary Drug-Eluting Stent sales for 2024 through 2030. With Coronary Drug-Eluting Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coronary Drug-Eluting Stent industry.
This Insight Report provides a comprehensive analysis of the global Coronary Drug-Eluting Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coronary Drug-Eluting Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coronary Drug-Eluting Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coronary Drug-Eluting Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coronary Drug-Eluting Stent.
United States market for Coronary Drug-Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Coronary Drug-Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Coronary Drug-Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Coronary Drug-Eluting Stent players cover Medtronic, Boston Scientific, Abbott, B.Braun and Biosensors International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Coronary Drug-Eluting Stent market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Polymer Stent
- Polymer-Free Stent
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- Abbott
- B.Braun
- Biosensors International
- MicroPort
- Lepu Medical
- Terumo
- Blue Sail Medical
- SINOMED
- Liaoning Yinyi Biological
What is the 10-year outlook for the global Coronary Drug-Eluting Stent market?
What factors are driving Coronary Drug-Eluting Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coronary Drug-Eluting Stent market opportunities vary by end market size?
How does Coronary Drug-Eluting Stent break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Coronary Drug-Eluting Stent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Coronary Drug-Eluting Stent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Coronary Drug-Eluting Stent by Country/Region, 2019, 2023 & 2030
2.2 Coronary Drug-Eluting Stent Segment by Type
2.2.1 Polymer Stent
2.2.2 Polymer-Free Stent
2.2.3 Others
2.3 Coronary Drug-Eluting Stent Sales by Type
2.3.1 Global Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
2.3.2 Global Coronary Drug-Eluting Stent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Coronary Drug-Eluting Stent Sale Price by Type (2019-2024)
2.4 Coronary Drug-Eluting Stent Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Coronary Drug-Eluting Stent Sales by Application
2.5.1 Global Coronary Drug-Eluting Stent Sale Market Share by Application (2019-2024)
2.5.2 Global Coronary Drug-Eluting Stent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Coronary Drug-Eluting Stent Sale Price by Application (2019-2024)
3 GLOBAL CORONARY DRUG-ELUTING STENT BY COMPANY
3.1 Global Coronary Drug-Eluting Stent Breakdown Data by Company
3.1.1 Global Coronary Drug-Eluting Stent Annual Sales by Company (2019-2024)
3.1.2 Global Coronary Drug-Eluting Stent Sales Market Share by Company (2019-2024)
3.2 Global Coronary Drug-Eluting Stent Annual Revenue by Company (2019-2024)
3.2.1 Global Coronary Drug-Eluting Stent Revenue by Company (2019-2024)
3.2.2 Global Coronary Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
3.3 Global Coronary Drug-Eluting Stent Sale Price by Company
3.4 Key Manufacturers Coronary Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coronary Drug-Eluting Stent Product Location Distribution
3.4.2 Players Coronary Drug-Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CORONARY DRUG-ELUTING STENT BY GEOGRAPHIC REGION
4.1 World Historic Coronary Drug-Eluting Stent Market Size by Geographic Region (2019-2024)
4.1.1 Global Coronary Drug-Eluting Stent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Coronary Drug-Eluting Stent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Coronary Drug-Eluting Stent Market Size by Country/Region (2019-2024)
4.2.1 Global Coronary Drug-Eluting Stent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Coronary Drug-Eluting Stent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Coronary Drug-Eluting Stent Sales Growth
4.4 APAC Coronary Drug-Eluting Stent Sales Growth
4.5 Europe Coronary Drug-Eluting Stent Sales Growth
4.6 Middle East & Africa Coronary Drug-Eluting Stent Sales Growth
5 AMERICAS
5.1 Americas Coronary Drug-Eluting Stent Sales by Country
5.1.1 Americas Coronary Drug-Eluting Stent Sales by Country (2019-2024)
5.1.2 Americas Coronary Drug-Eluting Stent Revenue by Country (2019-2024)
5.2 Americas Coronary Drug-Eluting Stent Sales by Type
5.3 Americas Coronary Drug-Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coronary Drug-Eluting Stent Sales by Region
6.1.1 APAC Coronary Drug-Eluting Stent Sales by Region (2019-2024)
6.1.2 APAC Coronary Drug-Eluting Stent Revenue by Region (2019-2024)
6.2 APAC Coronary Drug-Eluting Stent Sales by Type
6.3 APAC Coronary Drug-Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Coronary Drug-Eluting Stent by Country
7.1.1 Europe Coronary Drug-Eluting Stent Sales by Country (2019-2024)
7.1.2 Europe Coronary Drug-Eluting Stent Revenue by Country (2019-2024)
7.2 Europe Coronary Drug-Eluting Stent Sales by Type
7.3 Europe Coronary Drug-Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Coronary Drug-Eluting Stent by Country
8.1.1 Middle East & Africa Coronary Drug-Eluting Stent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Coronary Drug-Eluting Stent Revenue by Country (2019-2024)
8.2 Middle East & Africa Coronary Drug-Eluting Stent Sales by Type
8.3 Middle East & Africa Coronary Drug-Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coronary Drug-Eluting Stent
10.3 Manufacturing Process Analysis of Coronary Drug-Eluting Stent
10.4 Industry Chain Structure of Coronary Drug-Eluting Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Coronary Drug-Eluting Stent Distributors
11.3 Coronary Drug-Eluting Stent Customer
12 WORLD FORECAST REVIEW FOR CORONARY DRUG-ELUTING STENT BY GEOGRAPHIC REGION
12.1 Global Coronary Drug-Eluting Stent Market Size Forecast by Region
12.1.1 Global Coronary Drug-Eluting Stent Forecast by Region (2025-2030)
12.1.2 Global Coronary Drug-Eluting Stent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Coronary Drug-Eluting Stent Forecast by Type
12.7 Global Coronary Drug-Eluting Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.1.3 Medtronic Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.2.3 Boston Scientific Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.3.3 Abbott Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 B.Braun
13.4.1 B.Braun Company Information
13.4.2 B.Braun Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.4.3 B.Braun Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 B.Braun Main Business Overview
13.4.5 B.Braun Latest Developments
13.5 Biosensors International
13.5.1 Biosensors International Company Information
13.5.2 Biosensors International Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.5.3 Biosensors International Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Biosensors International Main Business Overview
13.5.5 Biosensors International Latest Developments
13.6 MicroPort
13.6.1 MicroPort Company Information
13.6.2 MicroPort Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.6.3 MicroPort Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 MicroPort Main Business Overview
13.6.5 MicroPort Latest Developments
13.7 Lepu Medical
13.7.1 Lepu Medical Company Information
13.7.2 Lepu Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.7.3 Lepu Medical Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lepu Medical Main Business Overview
13.7.5 Lepu Medical Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.8.3 Terumo Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 Blue Sail Medical
13.9.1 Blue Sail Medical Company Information
13.9.2 Blue Sail Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.9.3 Blue Sail Medical Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Blue Sail Medical Main Business Overview
13.9.5 Blue Sail Medical Latest Developments
13.10 SINOMED
13.10.1 SINOMED Company Information
13.10.2 SINOMED Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.10.3 SINOMED Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 SINOMED Main Business Overview
13.10.5 SINOMED Latest Developments
13.11 Liaoning Yinyi Biological
13.11.1 Liaoning Yinyi Biological Company Information
13.11.2 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.11.3 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Liaoning Yinyi Biological Main Business Overview
13.11.5 Liaoning Yinyi Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Coronary Drug-Eluting Stent Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Coronary Drug-Eluting Stent by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Coronary Drug-Eluting Stent by Country/Region, 2019, 2023 & 2030
2.2 Coronary Drug-Eluting Stent Segment by Type
2.2.1 Polymer Stent
2.2.2 Polymer-Free Stent
2.2.3 Others
2.3 Coronary Drug-Eluting Stent Sales by Type
2.3.1 Global Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
2.3.2 Global Coronary Drug-Eluting Stent Revenue and Market Share by Type (2019-2024)
2.3.3 Global Coronary Drug-Eluting Stent Sale Price by Type (2019-2024)
2.4 Coronary Drug-Eluting Stent Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Coronary Drug-Eluting Stent Sales by Application
2.5.1 Global Coronary Drug-Eluting Stent Sale Market Share by Application (2019-2024)
2.5.2 Global Coronary Drug-Eluting Stent Revenue and Market Share by Application (2019-2024)
2.5.3 Global Coronary Drug-Eluting Stent Sale Price by Application (2019-2024)
3 GLOBAL CORONARY DRUG-ELUTING STENT BY COMPANY
3.1 Global Coronary Drug-Eluting Stent Breakdown Data by Company
3.1.1 Global Coronary Drug-Eluting Stent Annual Sales by Company (2019-2024)
3.1.2 Global Coronary Drug-Eluting Stent Sales Market Share by Company (2019-2024)
3.2 Global Coronary Drug-Eluting Stent Annual Revenue by Company (2019-2024)
3.2.1 Global Coronary Drug-Eluting Stent Revenue by Company (2019-2024)
3.2.2 Global Coronary Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
3.3 Global Coronary Drug-Eluting Stent Sale Price by Company
3.4 Key Manufacturers Coronary Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coronary Drug-Eluting Stent Product Location Distribution
3.4.2 Players Coronary Drug-Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CORONARY DRUG-ELUTING STENT BY GEOGRAPHIC REGION
4.1 World Historic Coronary Drug-Eluting Stent Market Size by Geographic Region (2019-2024)
4.1.1 Global Coronary Drug-Eluting Stent Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Coronary Drug-Eluting Stent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Coronary Drug-Eluting Stent Market Size by Country/Region (2019-2024)
4.2.1 Global Coronary Drug-Eluting Stent Annual Sales by Country/Region (2019-2024)
4.2.2 Global Coronary Drug-Eluting Stent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Coronary Drug-Eluting Stent Sales Growth
4.4 APAC Coronary Drug-Eluting Stent Sales Growth
4.5 Europe Coronary Drug-Eluting Stent Sales Growth
4.6 Middle East & Africa Coronary Drug-Eluting Stent Sales Growth
5 AMERICAS
5.1 Americas Coronary Drug-Eluting Stent Sales by Country
5.1.1 Americas Coronary Drug-Eluting Stent Sales by Country (2019-2024)
5.1.2 Americas Coronary Drug-Eluting Stent Revenue by Country (2019-2024)
5.2 Americas Coronary Drug-Eluting Stent Sales by Type
5.3 Americas Coronary Drug-Eluting Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coronary Drug-Eluting Stent Sales by Region
6.1.1 APAC Coronary Drug-Eluting Stent Sales by Region (2019-2024)
6.1.2 APAC Coronary Drug-Eluting Stent Revenue by Region (2019-2024)
6.2 APAC Coronary Drug-Eluting Stent Sales by Type
6.3 APAC Coronary Drug-Eluting Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Coronary Drug-Eluting Stent by Country
7.1.1 Europe Coronary Drug-Eluting Stent Sales by Country (2019-2024)
7.1.2 Europe Coronary Drug-Eluting Stent Revenue by Country (2019-2024)
7.2 Europe Coronary Drug-Eluting Stent Sales by Type
7.3 Europe Coronary Drug-Eluting Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Coronary Drug-Eluting Stent by Country
8.1.1 Middle East & Africa Coronary Drug-Eluting Stent Sales by Country (2019-2024)
8.1.2 Middle East & Africa Coronary Drug-Eluting Stent Revenue by Country (2019-2024)
8.2 Middle East & Africa Coronary Drug-Eluting Stent Sales by Type
8.3 Middle East & Africa Coronary Drug-Eluting Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coronary Drug-Eluting Stent
10.3 Manufacturing Process Analysis of Coronary Drug-Eluting Stent
10.4 Industry Chain Structure of Coronary Drug-Eluting Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Coronary Drug-Eluting Stent Distributors
11.3 Coronary Drug-Eluting Stent Customer
12 WORLD FORECAST REVIEW FOR CORONARY DRUG-ELUTING STENT BY GEOGRAPHIC REGION
12.1 Global Coronary Drug-Eluting Stent Market Size Forecast by Region
12.1.1 Global Coronary Drug-Eluting Stent Forecast by Region (2025-2030)
12.1.2 Global Coronary Drug-Eluting Stent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Coronary Drug-Eluting Stent Forecast by Type
12.7 Global Coronary Drug-Eluting Stent Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.1.3 Medtronic Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.2.3 Boston Scientific Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.3.3 Abbott Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 B.Braun
13.4.1 B.Braun Company Information
13.4.2 B.Braun Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.4.3 B.Braun Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 B.Braun Main Business Overview
13.4.5 B.Braun Latest Developments
13.5 Biosensors International
13.5.1 Biosensors International Company Information
13.5.2 Biosensors International Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.5.3 Biosensors International Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Biosensors International Main Business Overview
13.5.5 Biosensors International Latest Developments
13.6 MicroPort
13.6.1 MicroPort Company Information
13.6.2 MicroPort Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.6.3 MicroPort Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 MicroPort Main Business Overview
13.6.5 MicroPort Latest Developments
13.7 Lepu Medical
13.7.1 Lepu Medical Company Information
13.7.2 Lepu Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.7.3 Lepu Medical Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lepu Medical Main Business Overview
13.7.5 Lepu Medical Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.8.3 Terumo Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 Blue Sail Medical
13.9.1 Blue Sail Medical Company Information
13.9.2 Blue Sail Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.9.3 Blue Sail Medical Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Blue Sail Medical Main Business Overview
13.9.5 Blue Sail Medical Latest Developments
13.10 SINOMED
13.10.1 SINOMED Company Information
13.10.2 SINOMED Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.10.3 SINOMED Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 SINOMED Main Business Overview
13.10.5 SINOMED Latest Developments
13.11 Liaoning Yinyi Biological
13.11.1 Liaoning Yinyi Biological Company Information
13.11.2 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product Portfolios and Specifications
13.11.3 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Liaoning Yinyi Biological Main Business Overview
13.11.5 Liaoning Yinyi Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Coronary Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Coronary Drug-Eluting Stent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Polymer Stent
Table 4. Major Players of Polymer-Free Stent
Table 5. Major Players of Others
Table 6. Global Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 7. Global Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 8. Global Coronary Drug-Eluting Stent Revenue by Type (2019-2024) & ($ million)
Table 9. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 10. Global Coronary Drug-Eluting Stent Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 12. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 13. Global Coronary Drug-Eluting Stent Revenue by Application (2019-2024)
Table 14. Global Coronary Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 15. Global Coronary Drug-Eluting Stent Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Coronary Drug-Eluting Stent Sales by Company (2019-2024) & (K Units)
Table 17. Global Coronary Drug-Eluting Stent Sales Market Share by Company (2019-2024)
Table 18. Global Coronary Drug-Eluting Stent Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Coronary Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
Table 20. Global Coronary Drug-Eluting Stent Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Coronary Drug-Eluting Stent Producing Area Distribution and Sales Area
Table 22. Players Coronary Drug-Eluting Stent Products Offered
Table 23. Coronary Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Coronary Drug-Eluting Stent Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Coronary Drug-Eluting Stent Sales Market Share Geographic Region (2019-2024)
Table 28. Global Coronary Drug-Eluting Stent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Coronary Drug-Eluting Stent Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Coronary Drug-Eluting Stent Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Coronary Drug-Eluting Stent Sales Market Share by Country/Region (2019-2024)
Table 32. Global Coronary Drug-Eluting Stent Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Coronary Drug-Eluting Stent Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 35. Americas Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 36. Americas Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 38. Americas Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 39. Americas Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 40. APAC Coronary Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 41. APAC Coronary Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 42. APAC Coronary Drug-Eluting Stent Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Coronary Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 44. APAC Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 45. APAC Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 46. Europe Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 47. Europe Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 48. Europe Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 50. Europe Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 51. Europe Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Coronary Drug-Eluting Stent
Table 59. Key Market Challenges & Risks of Coronary Drug-Eluting Stent
Table 60. Key Industry Trends of Coronary Drug-Eluting Stent
Table 61. Coronary Drug-Eluting Stent Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Coronary Drug-Eluting Stent Distributors List
Table 64. Coronary Drug-Eluting Stent Customer List
Table 65. Global Coronary Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Coronary Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Coronary Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Coronary Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Coronary Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Coronary Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Coronary Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Coronary Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Coronary Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Coronary Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Coronary Drug-Eluting Stent Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Coronary Drug-Eluting Stent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Coronary Drug-Eluting Stent Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Coronary Drug-Eluting Stent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Medtronic Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 80. Medtronic Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 81. Medtronic Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. Boston Scientific Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 85. Boston Scientific Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 86. Boston Scientific Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Boston Scientific Main Business
Table 88. Boston Scientific Latest Developments
Table 89. Abbott Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Abbott Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 91. Abbott Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Abbott Main Business
Table 93. Abbott Latest Developments
Table 94. B.Braun Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. B.Braun Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 96. B.Braun Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. B.Braun Main Business
Table 98. B.Braun Latest Developments
Table 99. Biosensors International Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. Biosensors International Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 101. Biosensors International Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Biosensors International Main Business
Table 103. Biosensors International Latest Developments
Table 104. MicroPort Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. MicroPort Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 106. MicroPort Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. MicroPort Main Business
Table 108. MicroPort Latest Developments
Table 109. Lepu Medical Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 110. Lepu Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 111. Lepu Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Lepu Medical Main Business
Table 113. Lepu Medical Latest Developments
Table 114. Terumo Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 115. Terumo Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 116. Terumo Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Terumo Main Business
Table 118. Terumo Latest Developments
Table 119. Blue Sail Medical Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 120. Blue Sail Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 121. Blue Sail Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Blue Sail Medical Main Business
Table 123. Blue Sail Medical Latest Developments
Table 124. SINOMED Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 125. SINOMED Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 126. SINOMED Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. SINOMED Main Business
Table 128. SINOMED Latest Developments
Table 129. Liaoning Yinyi Biological Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 130. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 131. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Liaoning Yinyi Biological Main Business
Table 133. Liaoning Yinyi Biological Latest Developments
Table 1. Coronary Drug-Eluting Stent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Coronary Drug-Eluting Stent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Polymer Stent
Table 4. Major Players of Polymer-Free Stent
Table 5. Major Players of Others
Table 6. Global Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 7. Global Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 8. Global Coronary Drug-Eluting Stent Revenue by Type (2019-2024) & ($ million)
Table 9. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 10. Global Coronary Drug-Eluting Stent Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 12. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 13. Global Coronary Drug-Eluting Stent Revenue by Application (2019-2024)
Table 14. Global Coronary Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 15. Global Coronary Drug-Eluting Stent Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Coronary Drug-Eluting Stent Sales by Company (2019-2024) & (K Units)
Table 17. Global Coronary Drug-Eluting Stent Sales Market Share by Company (2019-2024)
Table 18. Global Coronary Drug-Eluting Stent Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Coronary Drug-Eluting Stent Revenue Market Share by Company (2019-2024)
Table 20. Global Coronary Drug-Eluting Stent Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Coronary Drug-Eluting Stent Producing Area Distribution and Sales Area
Table 22. Players Coronary Drug-Eluting Stent Products Offered
Table 23. Coronary Drug-Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Coronary Drug-Eluting Stent Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Coronary Drug-Eluting Stent Sales Market Share Geographic Region (2019-2024)
Table 28. Global Coronary Drug-Eluting Stent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Coronary Drug-Eluting Stent Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Coronary Drug-Eluting Stent Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Coronary Drug-Eluting Stent Sales Market Share by Country/Region (2019-2024)
Table 32. Global Coronary Drug-Eluting Stent Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Coronary Drug-Eluting Stent Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 35. Americas Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 36. Americas Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 38. Americas Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 39. Americas Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 40. APAC Coronary Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 41. APAC Coronary Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 42. APAC Coronary Drug-Eluting Stent Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Coronary Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 44. APAC Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 45. APAC Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 46. Europe Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 47. Europe Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 48. Europe Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 50. Europe Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 51. Europe Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Coronary Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Coronary Drug-Eluting Stent Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Coronary Drug-Eluting Stent Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Coronary Drug-Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Coronary Drug-Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Coronary Drug-Eluting Stent
Table 59. Key Market Challenges & Risks of Coronary Drug-Eluting Stent
Table 60. Key Industry Trends of Coronary Drug-Eluting Stent
Table 61. Coronary Drug-Eluting Stent Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Coronary Drug-Eluting Stent Distributors List
Table 64. Coronary Drug-Eluting Stent Customer List
Table 65. Global Coronary Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Coronary Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Coronary Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Coronary Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Coronary Drug-Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Coronary Drug-Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Coronary Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Coronary Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Coronary Drug-Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Coronary Drug-Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Coronary Drug-Eluting Stent Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Coronary Drug-Eluting Stent Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Coronary Drug-Eluting Stent Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Coronary Drug-Eluting Stent Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Medtronic Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 80. Medtronic Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 81. Medtronic Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. Boston Scientific Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 85. Boston Scientific Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 86. Boston Scientific Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Boston Scientific Main Business
Table 88. Boston Scientific Latest Developments
Table 89. Abbott Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Abbott Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 91. Abbott Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Abbott Main Business
Table 93. Abbott Latest Developments
Table 94. B.Braun Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. B.Braun Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 96. B.Braun Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. B.Braun Main Business
Table 98. B.Braun Latest Developments
Table 99. Biosensors International Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. Biosensors International Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 101. Biosensors International Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Biosensors International Main Business
Table 103. Biosensors International Latest Developments
Table 104. MicroPort Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. MicroPort Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 106. MicroPort Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. MicroPort Main Business
Table 108. MicroPort Latest Developments
Table 109. Lepu Medical Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 110. Lepu Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 111. Lepu Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Lepu Medical Main Business
Table 113. Lepu Medical Latest Developments
Table 114. Terumo Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 115. Terumo Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 116. Terumo Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Terumo Main Business
Table 118. Terumo Latest Developments
Table 119. Blue Sail Medical Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 120. Blue Sail Medical Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 121. Blue Sail Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Blue Sail Medical Main Business
Table 123. Blue Sail Medical Latest Developments
Table 124. SINOMED Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 125. SINOMED Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 126. SINOMED Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. SINOMED Main Business
Table 128. SINOMED Latest Developments
Table 129. Liaoning Yinyi Biological Basic Information, Coronary Drug-Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 130. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product Portfolios and Specifications
Table 131. Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Liaoning Yinyi Biological Main Business
Table 133. Liaoning Yinyi Biological Latest Developments
LIST OF FIGURES
Figure 1. Picture of Coronary Drug-Eluting Stent
Figure 2. Coronary Drug-Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coronary Drug-Eluting Stent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Coronary Drug-Eluting Stent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Coronary Drug-Eluting Stent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Polymer Stent
Figure 10. Product Picture of Polymer-Free Stent
Figure 11. Product Picture of Others
Figure 12. Global Coronary Drug-Eluting Stent Sales Market Share by Type in 2023
Figure 13. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Figure 14. Coronary Drug-Eluting Stent Consumed in Hospital
Figure 15. Global Coronary Drug-Eluting Stent Market: Hospital (2019-2024) & (K Units)
Figure 16. Coronary Drug-Eluting Stent Consumed in Clinic
Figure 17. Global Coronary Drug-Eluting Stent Market: Clinic (2019-2024) & (K Units)
Figure 18. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2023)
Figure 19. Global Coronary Drug-Eluting Stent Revenue Market Share by Application in 2023
Figure 20. Coronary Drug-Eluting Stent Sales Market by Company in 2023 (K Units)
Figure 21. Global Coronary Drug-Eluting Stent Sales Market Share by Company in 2023
Figure 22. Coronary Drug-Eluting Stent Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Coronary Drug-Eluting Stent Revenue Market Share by Company in 2023
Figure 24. Global Coronary Drug-Eluting Stent Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Coronary Drug-Eluting Stent Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 27. Americas Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 28. APAC Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 29. APAC Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 30. Europe Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 31. Europe Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 34. Americas Coronary Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 35. Americas Coronary Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 36. Americas Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 37. Americas Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 38. United States Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Coronary Drug-Eluting Stent Sales Market Share by Region in 2023
Figure 43. APAC Coronary Drug-Eluting Stent Revenue Market Share by Regions in 2023
Figure 44. APAC Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 45. APAC Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 46. China Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Coronary Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 54. Europe Coronary Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 55. Europe Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 56. Europe Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 57. Germany Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Coronary Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 66. Egypt Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Coronary Drug-Eluting Stent in 2023
Figure 72. Manufacturing Process Analysis of Coronary Drug-Eluting Stent
Figure 73. Industry Chain Structure of Coronary Drug-Eluting Stent
Figure 74. Channels of Distribution
Figure 75. Global Coronary Drug-Eluting Stent Sales Market Forecast by Region (2025-2030)
Figure 76. Global Coronary Drug-Eluting Stent Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Coronary Drug-Eluting Stent Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Coronary Drug-Eluting Stent Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Coronary Drug-Eluting Stent Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Coronary Drug-Eluting Stent Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Coronary Drug-Eluting Stent
Figure 2. Coronary Drug-Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coronary Drug-Eluting Stent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Coronary Drug-Eluting Stent Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Coronary Drug-Eluting Stent Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Polymer Stent
Figure 10. Product Picture of Polymer-Free Stent
Figure 11. Product Picture of Others
Figure 12. Global Coronary Drug-Eluting Stent Sales Market Share by Type in 2023
Figure 13. Global Coronary Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Figure 14. Coronary Drug-Eluting Stent Consumed in Hospital
Figure 15. Global Coronary Drug-Eluting Stent Market: Hospital (2019-2024) & (K Units)
Figure 16. Coronary Drug-Eluting Stent Consumed in Clinic
Figure 17. Global Coronary Drug-Eluting Stent Market: Clinic (2019-2024) & (K Units)
Figure 18. Global Coronary Drug-Eluting Stent Sales Market Share by Application (2023)
Figure 19. Global Coronary Drug-Eluting Stent Revenue Market Share by Application in 2023
Figure 20. Coronary Drug-Eluting Stent Sales Market by Company in 2023 (K Units)
Figure 21. Global Coronary Drug-Eluting Stent Sales Market Share by Company in 2023
Figure 22. Coronary Drug-Eluting Stent Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Coronary Drug-Eluting Stent Revenue Market Share by Company in 2023
Figure 24. Global Coronary Drug-Eluting Stent Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Coronary Drug-Eluting Stent Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 27. Americas Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 28. APAC Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 29. APAC Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 30. Europe Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 31. Europe Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Coronary Drug-Eluting Stent Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Coronary Drug-Eluting Stent Revenue 2019-2024 ($ Millions)
Figure 34. Americas Coronary Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 35. Americas Coronary Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 36. Americas Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 37. Americas Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 38. United States Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Coronary Drug-Eluting Stent Sales Market Share by Region in 2023
Figure 43. APAC Coronary Drug-Eluting Stent Revenue Market Share by Regions in 2023
Figure 44. APAC Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 45. APAC Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 46. China Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Coronary Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 54. Europe Coronary Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 55. Europe Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 56. Europe Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 57. Germany Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Coronary Drug-Eluting Stent Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Coronary Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Figure 66. Egypt Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Coronary Drug-Eluting Stent Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Coronary Drug-Eluting Stent in 2023
Figure 72. Manufacturing Process Analysis of Coronary Drug-Eluting Stent
Figure 73. Industry Chain Structure of Coronary Drug-Eluting Stent
Figure 74. Channels of Distribution
Figure 75. Global Coronary Drug-Eluting Stent Sales Market Forecast by Region (2025-2030)
Figure 76. Global Coronary Drug-Eluting Stent Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Coronary Drug-Eluting Stent Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Coronary Drug-Eluting Stent Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Coronary Drug-Eluting Stent Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Coronary Drug-Eluting Stent Revenue Market Share Forecast by Application (2025-2030)
